GUANGZHOU, China

Kun Shao

This inventor holds 1 USPTO granted patent. Top assignee: Guangzhou Eec Biotech Development Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kun Shao. Retrieved from https://idiyas.com/inventor/kun-shao-4jzvgcdg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kun Shao: Innovator in Chlorin Derivatives and Ultrasonic Medical Systems

Introduction

Kun Shao is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of medical technology, particularly in the development of chlorin derivatives for therapeutic applications. His innovative work focuses on enhancing cancer treatment through advanced methodologies.

Latest Patents

Kun Shao holds a patent for "Chlorin derivatives or pharmaceutically acceptable salts thereof, preparation method and use thereof, and combination thereof with an ultrasonic medical system." This patent describes a chlorin derivative or a pharmaceutically acceptable salt, along with its preparation method and application in anti-tumor compositions. The invention emphasizes the use of these chlorin derivatives in photodynamic and sonodynamic therapies, which are effective in inhibiting and treating cancer.

Career Highlights

Kun Shao is associated with Guangzhou Eec Biotech Development Co., Ltd., where he applies his expertise in developing innovative medical solutions. His work has garnered attention for its potential impact on cancer treatment methodologies.

Collaborations

He collaborates with notable colleagues, including Qing Li and Xiaohuai Wang, to advance research and development in the field of medical technology.

Conclusion

Kun Shao's contributions to the field of chlorin derivatives and ultrasonic medical systems highlight his commitment to improving cancer treatment. His innovative approaches pave the way for future advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…